Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shalala on herbals advertising

This article was originally published in The Tan Sheet

Executive Summary

HHS Secretary Donna Shalala voices concern with herbal supplement ads on National Public Radio's Dianne Rehm Show Feb. 3. Initially responding to a question about direct-to-consumer advertising for Rx pharmaceuticals, Shalala said: "I'm much more worried about people who don't go through the FDA - about the herbal products - that are beginning to advertise on radio as well as on television and in other kinds of ads, claiming health outcomes without the scientific basis." Continuing, she said: "I think people have to be very careful to make sure that what they put in their bodies is approved by the FDA [and] has gone through careful and high scientific standards." Shalala also referred to FDA's recent regulatory actions against GBL manufacturers

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

PS089401

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel